HIV and viral hepatitis co-infection in New York City, 2000–2010: prevalence and case characteristics

Prussing, Catharine; Chan, CK; Pinchoff, Jessie; Kersanske, Laura; Bornschlegel, Katherine; Balter, Sharon; Drobnik, Ann; Fuld, Jennifer

doi:10.1017/s0950268814002209

Cited by 23 publications

(19 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Persons who inject drugs are also more likely to have other comorbidities, such as hepatitis-C infection and mental illnesses, and also face health-care access challenges 20-23 . A study in New York City found that among HIV-HCV co-infected individuals, 60% had their infection attributed to injection drug use 22 .…”

Section: Discussionmentioning

confidence: 99%

Population-Based Estimates of Life Expectancy After HIV Diagnosis

Siddiqi

Hall

et al. 2016

JAIDS Journal of Acquired Immune Deficiency Syndromes

View full text Add to dashboard Cite

Introduction Using National HIV surveillance system data we estimated life expectancy and average years of life lost among person diagnosed with HIV infection during 2008–2011. Methods Population-based surveillance data, restricted to persons with diagnosed HIV infection age 13 years or older, from all 50 states and D.C. were used to estimate life expectancy after HIV diagnosis using the life table method. Generated estimates were compared with life expectancy in the general population in the same calendar year to calculate average years of life lost (AYLL). Life expectancy and average years of life lost were also estimated for subgroups by age, sex and race/ethnicity. Results The overall life expectancy after HIV diagnosis in the United States, increased 3.43 years from 25.43 (95% Confidence interval (CI) 25.37–25.49) in 2008, to 28.86 (95% CI 28.80–28.92) in 2011. Improvements were observed irrespective of sex, race/ethnicity, transmission category and stage of disease at diagnosis, though the extent of improvement varied by different characteristics. Based on the life expectancy in the general population, in 2010 the AYLL, were 12.8 years for males and 16.5 years for females. By race/ethnicity, on average blacks (13.3 years) and whites (13.4 years) had fewer AYLL than Hispanic/Latinos (14.7). Conclusions Despite improvements in life expectancy among people diagnosed with an HIV infection during 2008–2011, disparities by sex and by race/ethnicity persist. Targeted efforts should continue to further reduce disparities and improve life expectancy after HIV diagnosis.

show abstract

Section: Discussionmentioning

confidence: 99%

Population-Based Estimates of Life Expectancy After HIV Diagnosis

Siddiqi

Hall

et al. 2016

JAIDS Journal of Acquired Immune Deficiency Syndromes

View full text Add to dashboard Cite

show abstract

“…Health departments’ surveillance activities for HIV, acute and chronic HBV, and acute and chronic HCV vary by jurisdiction. Although some health departments have used their surveillance data to quantify the number and characteristics of HIV and viral hepatitis coinfections, approaches used for identifying coinfections and analysing results vary greatly [23–27]. Routine linkages of HIV and viral hepatitis surveillance data are necessary to monitor health status, including assessments of the risk for a geographically focused outbreak [28].…”

Section: Introductionmentioning

confidence: 99%

HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities

et al. 2018

View full text Add to dashboard Cite

SUMMARY Coinfection with human immunodeficiency virus (HIV) and viral hepatitis is associated with high morbidity and mortality in the absence of clinical management, making identification of these cases crucial. We examined characteristics of HIV and viral hepatitis coinfections by using surveillance data from 15 US states and 2 cities. Each jurisdiction used an automated deterministic matching method to link surveillance data for persons with reported acute and chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections, to persons reported with HIV infection. Of the 504398 persons living with diagnosed HIV infection at the end of 2014, 2.0% were coinfected with HBV, and 6.7% were coinfected with HCV. Of the 269884 persons ever reported with HBV, 5.2% were reported with HIV. Of the 1093050 persons ever reported with HCV, 4.3% were reported with HIV. A greater proportion of persons coinfected with HIV and HBV were males and blacks/African Americans, compared with those with HIV monoinfection. Persons who inject drugs represented a greater proportion of those coinfected with HIV and HCV, compared with those with HIV monoinfection. Matching HIV and viral hepatitis surveillance data highlights epidemiological characteristics of persons coinfected and can be used to routinely monitor health status and guide state and national public health interventions.

show abstract

“…As observed previously,2 the current findings suggest similar continued racial and ethnic disparities in rates of HCV diagnosis among MSM with HIV. Other studies have also found that the HCV disease burden disproportionately affects non-Latino blacks and Latinos 18 19…”

Section: Discussionmentioning

confidence: 97%

Hepatitis C infection among men who have sex with men living with HIV in New York City, 2000–2015

et al. 2019

View full text Add to dashboard Cite

ObjectivesTo calculate the rate of hepatitis C virus (HCV) among HIV-infected men who have sex with men (MSM) with no reported history of injection drug use (IDU), and to assess whether disparities exist in HIV/HCV coinfection by race/ethnicity and neighbourhood poverty level within this population in New York City.MethodsHIV-positive men who reported sex with men and did not report IDU at the time of HIV diagnosis, diagnosed through 2015 and alive as of 2000, were matched to people with HCV first reported to the New York City Department of Health and Mental Hygiene between 2000 and 2015. Those with HCV reported before or within 90 days of HIV infection were excluded. A multivariable Cox proportional hazards model was fit to compare the association between HCV diagnosis, race/ethnicity and neighbourhood poverty level.ResultsFrom 2000 to 2015, 54 488 non-IDU MSM were diagnosed with HIV, of whom 2762 (5.1%) were diagnosed with HCV after HIV diagnosis, yielding an overall age-adjusted HCV diagnosis rate of 512 per 100 000 person-years. HIV/HCV coinfection was significantly higher among non-Latino blacks (adjusted HR (aHR)=1.24, 95% CI 1.11 to 1.40) compared with non-Latino whites and among persons living in high-poverty neighbourhoods compared with those in low-poverty neighbourhoods (aHR=1.17, 95% CI 1.01 to 1.35) after stratification by year of HIV diagnosis.ConclusionDisparities in HIV/HCV coinfection among HIV-positive MSM were observed by race/ethnicity and neighbourhood poverty level. Routine HCV screening is recommended for people infected with HIV. People coinfected with HIV and HCV should be linked to HCV care, treated and cured to reduce morbidity and mortality, and to avoid ongoing HCV transmission.

show abstract

HIV and viral hepatitis co-infection in New York City, 2000–2010: prevalence and case characteristics

Cited by 23 publications

References 30 publications

Population-Based Estimates of Life Expectancy After HIV Diagnosis

Population-Based Estimates of Life Expectancy After HIV Diagnosis

HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities

Hepatitis C infection among men who have sex with men living with HIV in New York City, 2000–2015

Contact Info

Product

Resources

About